Google DeepMind has released AlphaGenome Atlas, an AI-generated database that predicts the effects of every possible single-letter change in human DNA. The tool is presented as a precomputed “map” designed to help researchers interpret how genetic variation influences biology and disease.

Multiple outlets describe the atlas as covering about 9 billion possible substitutions and aiming to support both protein-coding regions and regulatory DNA, which can control gene on/off activity. Scientific American and Singularity Hub focus on how the system forecasts the impact of DNA mutations, while The Verge and The Next Web emphasize potential downstream uses, including speeding research into genetic diseases and potentially supporting the development of new treatments.

Sources also note how the atlas was validated and how it will be accessed. The Next Web reports that validations draw on UK Biobank whole-genome data and work from the Broad Institute, while Slashdot and The Verge discuss access options. DeepMind makes the atlas available for non-commercial use via a website and says commercial availability will come through Google Cloud under a licensing arrangement. A related research paper is released as a preprint on bioRxiv.